Who we are

The Canadian Clinical Trials Coordinating Centre was created to implement an action plan to strengthen and improve clinical trials in Canada and streamline processes for companies and researchers.

Developed through extensive stakeholder consultation, the action plan includes nine key recommendations to improve the coordination of clinical trials in Canada, increase participation in trials, and strategically raise Canada’s profile among international companies. Those recommendations are summarized in the report "To Your Health and Prosperity – An Action Plan to Help Attract More Clinical Trials to Canada."

The CCTCC is a collaborative effort of the Canadian Institutes of Health Research (CIHR), Innovative Medicines Canada, and HealthCareCAN.

What are clinical trials and why are they important?

Clinical trials involve testing new therapies with patients. They are a critical step toward bringing new medicines, effective vaccines, and innovative medical devices safely to market. They can result in better medical treatments, better quality of life, cost savings to Canada’s health system, new jobs, and revenue for the Canadian economy. Most importantly, clinical trials have the potential to relieve pain and suffering, and to reverse or halt the effects of disease or disability for Canadian patients.

Learn More

Quick Facts

  • The CCTAM is a robust, online, searchable database designed to communicate 
    Canada’s clinical research strengths to all stakeholders, including clinical trial sponsors. Its purpose is to: 

    • Better enable sponsors of clinical trials to identify clinical research sites and investigators, and facilitate the conduct of feasibility assessments. 
    • Become a comprehensive database for all Canadian clinical research assets; the essential tool for anyone planning to conduct clinical research in Canada. 
    • Position Canada as an attractive destination for the conduct of clinical trials in the global marketplace. 



  • HealthCareCAN is the national voice of healthcare organizations in Canada. They foster continuous, results-oriented discovery and innovation across the continuum of healthcare. They act with others to enhance the health of all Canadians; to build the capability for high quality care; and to help ensure value for money in publicly financed, healthcare programs.

  • Innovative Medicines Canada (formerly known as Rx&D) is the association of leading research-based pharmaceutical companies dedicated to improving the health of all Canadians through the discovery and development of new medicines and vaccines.

    Their mission is to advocate for policies that will bring the best innovative medicines and vaccines to Canadians in a timely an appropriate manner; improve Canada’s global competitiveness; and make Canada a world leader in attracting pharmaceutical and biotechnology investments.

  • SPOR is a national coalition of federal, provincial and territorial partners (patient advocates, provincial health authorities, academic health centres, charities, philanthropic organizations, pharmaceutical sector) dedicated to the integration of research into care.